CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | Garg Pushkal CMO & EVP Dev & Med Affairs | Option exercise · Restricted Stock Units | −1,908 | 1,908 | ||
| 2025-02-18 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −1,086 | $250.21 | $272K | 13,235 |
| 2025-02-18 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −115 | $251.60 | $29K | 13,120 |
| 2025-02-18 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −80 | $256.05 | $20K | 13,040 |
| 2025-02-18 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −76 | $257.79 | $20K | 12,964 |
| 2025-02-18 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −83 | $259.10 | $22K | 12,881 |
| 2025-02-18 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale 10b5-1 | −862 | $250.11 | $216K | 12,675 |
| 2025-02-18 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale 10b5-1 | −306 | $250.73 | $77K | 12,369 |
| 2025-02-18 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale 10b5-1 | −110 | $251.60 | $28K | 12,259 |
| 2025-02-18 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale 10b5-1 | −83 | $256.05 | $21K | 12,176 |
| 2025-02-18 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale 10b5-1 | −107 | $257.99 | $28K | 12,069 |
| 2025-02-18 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale 10b5-1 | −80 | $259.10 | $21K | 11,989 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −271 | $252.50 | $68K | 82,468 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −300 | $253.37 | $76K | 82,168 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −201 | $254.35 | $51K | 81,967 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −85 | $255.56 | $22K | 81,882 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −98 | $256.29 | $25K | 81,784 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −47 | $257.51 | $12K | 81,737 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −59 | $258.07 | $15K | 81,678 |
| 2025-02-14 | Greenstreet Yvonne Chief Executive Officer | Sale | −21 | $259.72 | $5K | 81,657 |
Page 36 of 41 · 816 trades